IRADIMED CORP Reports Q2 2026 Financial Results

What Happened
IRADIMED CORPORATION announced its financial results for the quarter ended June 30, 2026 in a press release dated July 31, 2026. The company furnished that press release as Exhibit 99.1 to its Form 8-K (Item 2.02: Results of Operations and Financial Condition). The Form 8-K was signed by John Glenn, Chief Financial Officer, on July 31, 2026.

Key Details

• Press release date: July 31, 2026; covers quarter ended June 30, 2026.
• Filing: Current Report on Form 8-K (Item 2.02) furnished the press release as Exhibit 99.1.
• Administrative: Form 8-K included interactive cover page data (Inline XBRL) as noted in exhibits.
• Authorized signatory: John Glenn, Chief Financial Officer, signed the report on July 31, 2026.

Why It Matters
This 8-K alerts investors that IRADIMED has publicly reported its latest quarterly results; the press release is the first source for updated earnings, revenue and operational metrics for the period. Retail investors should read the furnished press release (Exhibit 99.1) and await the company’s subsequent SEC filings (e.g., Form 10-Q) for full financial statements, detailed figures and any management commentary that could affect valuation or near-term trading decisions.